{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T05:08:49Z","timestamp":1734066529144,"version":"3.30.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113519","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T20:46:31Z","timestamp":1731789991000},"page":"113519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["The impact of rhG-CSF on risk of recurrence after postoperative chemotherapy in NSCLC Patients: A retrospective cohort study"],"prefix":"10.1016","volume":"143","author":[{"given":"Tong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2342-088X","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2024.113519_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: a cancer journal for clinicians"},{"issue":"5","key":"10.1016\/j.intimp.2024.113519_b0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship[J\/OL]","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.intimp.2024.113519_b0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jtcvs.2012.09.030","article-title":"Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance[J\/OL]","volume":"145","author":"Lou","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.intimp.2024.113519_b0020","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.5306\/wjco.v5.i5.1048","article-title":"Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer[J\/OL]","volume":"5","author":"Yano","year":"2014","journal-title":"World Journal of Clinical Oncology"},{"issue":"11","key":"10.1016\/j.intimp.2024.113519_b0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11095-018-2491-5","article-title":"Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product[J\/OL]","volume":"35","author":"Halim","year":"2018","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.113519_b0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.21147\/j.issn.1000-9604.2017.05.04","article-title":"A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia[J\/OL]","volume":"29","author":"Qin","year":"2017","journal-title":"Chin. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.113519_b0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2159-8290.CD-15-1157","article-title":"Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells[J\/OL]","volume":"6","author":"Spiegel","year":"2016","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.intimp.2024.113519_b0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumor-Associated Macrophages as Treatment Targets in Oncology[J\/OL]","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113519_b0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12885-022-09850-4","article-title":"rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy[J\/OL]","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cancer"},{"issue":"23","key":"10.1016\/j.intimp.2024.113519_b0050","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2013.53.4115","article-title":"Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer[J\/OL]","volume":"32","author":"Fernando","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2024.113519_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s11658-020-00216-x","article-title":"MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C[J\/OL]","volume":"25","author":"Liao","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.113519_b0060","doi-asserted-by":"crossref","first-page":"824","DOI":"10.21037\/tlcr-22-723","article-title":"Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectives[J\/OL]","volume":"12","author":"Kris","year":"2023","journal-title":"Translational Lung Cancer Research"},{"key":"10.1016\/j.intimp.2024.113519_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6165","article-title":"Molecular risk factors for locoregional recurrence in resected non-small cell lung cancer[J\/OL]","author":"Guo","year":"2023","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.113519_b0070","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.athoracsur.2012.03.031","article-title":"Tumor recurrence after complete resection for non-small cell lung cancer[J\/OL]","volume":"93","author":"Taylor","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.intimp.2024.113519_b0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3389\/fonc.2020.00715","article-title":"Patterns of Extrathoracic Metastases in Different Histological Types of Lung Cancer[J\/OL]","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113519_b0080","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.21037\/tlcr-22-148","article-title":"Prognosis and recurrence patterns in patients with early stage lung cancer: a multi-state model approach[J\/OL]","volume":"11","author":"Jeong","year":"2022","journal-title":"Translational Lung Cancer Research"},{"issue":"5","key":"10.1016\/j.intimp.2024.113519_b0085","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203431","article-title":"Prediction of prognosis of patients with lung cancer in combination with the immune score","volume":"41","author":"Han","year":"2021","journal-title":"Bioscience Reports"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.113519_b0090","doi-asserted-by":"crossref","first-page":"P30","DOI":"10.1186\/1470-7330-14-S1-P30","article-title":"Potential influence of automated volumetry on treatment response classifications in lung cancer lesions[J\/OL]","volume":"14","author":"Akbari","year":"2014","journal-title":"Cancer Imaging"},{"issue":"21","key":"10.1016\/j.intimp.2024.113519_b0095","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group[J\/OL]","volume":"26","author":"Pignon","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.intimp.2024.113519_b0100","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","article-title":"Immunotherapy of Melanoma: Facts and Hopes[J\/OL]","volume":"25","author":"Weiss","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113519_b0105","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/1541-7786.MCR-07-2170","article-title":"The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls CSF-1 mRNA stability in ovarian cancer[J\/OL]","volume":"6","author":"Zhou","year":"2008","journal-title":"Molecular Cancer Research: MCR"},{"issue":"34","key":"10.1016\/j.intimp.2024.113519_b0110","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/onc.2013.542","article-title":"Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells[J\/OL]","volume":"33","author":"Barbetti","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.113519_b0115","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.12659\/MSM.909128","article-title":"Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival[J\/OL]","volume":"24","author":"Fan","year":"2018","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"issue":"2","key":"10.1016\/j.intimp.2024.113519_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12032-022-01935-1","article-title":"Breast tumor metastasis following filgrastim administration due to the SDF-1\/CXCR4 pathway[J\/OL]","volume":"40","author":"Khalighfard","year":"2023","journal-title":"Medical Oncology (Northwood, London, England)"},{"issue":"4","key":"10.1016\/j.intimp.2024.113519_b0125","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1002\/jcp.26075","article-title":"Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis[J\/OL]","volume":"233","author":"Safarzadeh","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113519_b0130","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/0008-5472.CAN-14-3000","article-title":"Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production[J\/OL]","volume":"75","author":"Chafe","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.113519_b0135","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/jcmm.14858","article-title":"Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway[J\/OL]","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"18","key":"10.1016\/j.intimp.2024.113519_b0140","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1038\/onc.2016.406","article-title":"Neutrophil extracellular traps: protagonists of cancer progression?[J\/OL]","volume":"36","author":"Erpenbeck","year":"2017","journal-title":"Oncogene"},{"issue":"361","key":"10.1016\/j.intimp.2024.113519_b0145","doi-asserted-by":"crossref","first-page":"361ra138","DOI":"10.1126\/scitranslmed.aag1711","article-title":"Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps[J\/OL]","volume":"8","author":"Park","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113519_b0150","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1038\/s41467-021-26556-6","article-title":"Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis[J\/OL]","volume":"12","author":"Yip","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2024.113519_b0155","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3390\/cancers15092626","article-title":"c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities[J\/OL]","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.intimp.2024.113519_b0160","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1038\/s41467-021-26556-6","article-title":"Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis","volume":"12","author":"Yip","year":"2021","journal-title":"Nature communications"},{"issue":"18","key":"10.1016\/j.intimp.2024.113519_b0165","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.7150\/jca.63159","article-title":"Treatment with Granulocyte-colony Stimulating Factor (G-CSF) is not associated with Increased Risk of Brain Metastasis in Patients with De Novo Stage IV Breast Cancer[J\/OL]","volume":"12","author":"Fujii","year":"2021","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2024.113519_b0170","first-page":"2019","article-title":"The role of granulocyte colony-stimulating factor in breast cancer development: A review[J\/OL]","volume":"21","author":"Liu","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"15","key":"10.1016\/j.intimp.2024.113519_b0175","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","article-title":"EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours","volume":"42","author":"Aapro","year":"2006","journal-title":"European Journal of Cancer (Oxford, England: 1990)"},{"issue":"28","key":"10.1016\/j.intimp.2024.113519_b0180","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update[J\/OL]","volume":"33","author":"Smith","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113519_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cllc.2015.12.002","article-title":"A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)[J\/OL]","volume":"17","author":"Zhou","year":"2016","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.intimp.2024.113519_b0190","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s40064-015-1067-7","article-title":"Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy[J\/OL]","volume":"4","author":"Volovat","year":"2015","journal-title":"Springerplus"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924020411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924020411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T04:21:14Z","timestamp":1733977274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924020411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"alternative-id":["S1567576924020411"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113519","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of rhG-CSF on risk of recurrence after postoperative chemotherapy in NSCLC Patients: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113519"}}